Search results for " Venere"

showing 10 items of 540 documents

Clinical features and molecular genetic analysis in a Turkish family with oral white sponge nevus

2018

Background Oral white sponge nevus (WSN) is a rare autosomal dominant benign condition, characterized by asymptomatic spongy white plaques. Mutations in Keratin 4 (KRT4) and 13 (KRT13) have been shown to cause WSN. Familial cases are uncommon due to irregular penetrance. Thus, the aim of the study was: a) to demonstrate the clinical and histopathological features of a three-generation Turkish family with oral WSN b) to determine whether KRT4 or KRT13 gene mutation was the molecular basis of WSN. Material and Methods Out of twenty members of the family ten were available for assessment. Venous blood samples from six affected and five unaffected members and 48 healthy controls were obtained f…

AdultMaleTurkish populationAdolescentTurkeyLeukokeratosis Hereditary MucosalGene mutationBiology030207 dermatology & venereal diseases03 medical and health sciencesExonYoung Adult0302 clinical medicineWhite sponge nevusmedicineHumansChildGeneral DentistryGeneAllele frequencyGeneticsOral Medicine and PathologyResearchKeratin-13030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasePenetrancePedigreeOtorhinolaryngologyKeratin 4Case-Control StudiesUNESCO::CIENCIAS MÉDICASCytogenetic AnalysisMutationbiology.proteinSurgeryKeratin-4Medicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Body hair removal: Prevalence, demographics, and body experience among men and women in Germany

2020

Background: Body hair removal is an increasing trend that has an impact on the individual's body image. Aims: To characterize current body hair removal practices in Germany and the extent to which body hair removal was related to demographic characteristics, body image, and body mass index. Patients/Methods: A national survey was conducted from September to October 2016 in men and women in Germany. Body experience was measured by a standardized questionnaire. In addition to sociodemographic data, age, gender, education, marital status, monthly income, and body mass index were collected. Results: A total of n = 2510 participants aged 14 to 94 years (Mage = 48.4 years (SD = 18.2), 53.4% femal…

AdultMaleYounger ageAdolescentDemographicsPopulationDermatologyHair RemovalPubic hairYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAxillary hairGermanyPrevalenceHair removalmedicineHumans610.72educationAgedAged 80 and overNational surveyeducation.field_of_studyintegumentary systembusiness.industryBody hair removalMiddle AgedPubic hairBody hairBody imagemedicine.anatomical_structure030220 oncology & carcinogenesisMarital statusFemalebusinessBody mass indexHairDemographyJournal of Cosmetic Dermatology
researchProduct

Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data

2018

Background The X-ACT study aims to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H1-antihistamines. Methods In X-ACT, a phase III, double-blind, placebo-controlled study, CSU patients (18–75 years) with ≥4 angioedema episodes during the 6 months before inclusion were randomized (1:1) to receive omalizumab 300 mg or placebo every 4 weeks for 28 weeks. Angioedema-related QoL, skin-related QoL impairment, and psychological well-being were assessed. Results Ninety-one patients were randomized and 68 (omalizumab, n=35; placebo, n=33) completed the 28-week treatment period. At baselin…

AdultMalechronic spontaneous urticariamedicine.medical_specialtyAdolescentUrticariaImmunologyOmalizumab600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::616 KrankheitenPlaceboYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRefractoryQuality of lifeInternal medicine616Anti-Allergic AgentsmedicineHumansH1-antihistamine-refractoryImmunology and AllergyDepression (differential diagnoses)AgedAngioedemaAdult patientsbusiness.industryangioedemaDermatology Life Quality IndexMiddle AgedSurgeryquality of life030228 respiratory systemExperimental Allergy and ImmunologyomalizumabOriginal ArticleFemaleORIGINAL ARTICLESH1‐antihistamine‐refractorymedicine.symptombusinessmedicine.drugAllergy
researchProduct

Chronic skin disease and levels of physical activity in 17 777 Spanish adults: a cross-sectional study

2021

Background: To date there is limited literature on the prevalence of chronic skin conditions and its association with levels of physical activity (PA) in Spain. Aim: To determine the prevalence of chronic skin disease and to compare levels of PA between people with and without chronic skin disease in a large representative sample of Spanish adults aged 15–69 years. Methods: Data from the Spanish National Health Survey 2017 were analysed. Chronic skin disease was assessed using a yes/no question. PA was measured using the short form of the International Physical Activity Questionnaire. Total PA metabolic equivalent of task min/week were calculated, and PA was included in the analyses as a co…

AdultMalemedicine.medical_specialtyAdolescentCross-sectional study[SDV]Life Sciences [q-bio]Physical activityDermatologyNegative associationSkin DiseasesMetabolic equivalentYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinePrevalencemedicineHumansChronic skin diseaseSex DistributionExerciseAgedNational healthbusiness.industryConfoundingOdds ratioMiddle AgedCross-Sectional StudiesChronic skin diseaseSpain030220 oncology & carcinogenesisChronic DiseaseFemalebusiness
researchProduct

Prevalence of acne vulgaris and its clinico-epidemiological pattern in adult patients: Results of a prospective, observational study.

2021

Background Acne is a common disorder in adolescents. The prevalence of acne in adults is also increasing. There are only a few Indian studies on the prevalence and clinical features of adult acne. Aims To evaluate the prevalence and possible etiological and aggravating factors of acne in adult population. Methods Adult patients more than 25 years with acne were enrolled, and detailed history and examination were recorded. Type of acne, age, gender, area of involvement, and associated factors were noted. Results Out of 24,056 adult patients, 180 had acne, with the prevalence of 0.74%. Mean age of patients with acne was 30.1 years. A total of 81.7% patients with acne were female and 68.3% had…

AdultMalemedicine.medical_specialtyAdolescentDermatologyCosmetics030207 dermatology & venereal diseases03 medical and health sciencesCicatrix0302 clinical medicineEpidemiologyAcne VulgarismedicinePrevalenceHumansProspective StudiesFamily historyhirsutismAcneGlycemicbusiness.industrymedicine.diseaseDermatology030220 oncology & carcinogenesisEtiologyPopulation studyObservational studyFemalebusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled …

2016

Background Chronic spontaneous urticaria (CSU) severely impacts quality of life (QoL), especially in patients with wheals and angioedema. Omalizumab is approved as add-on therapy for CSU patients; however, its effect on patients who are double-positive for wheals and angioedema has not been systematically studied. Objective The primary objective was to evaluate the efficacy of omalizumab vs placebo at week 28 using the Chronic Urticaria Quality of Life (CU-Q2oL) questionnaire. Number of angioedema-burdened days, time interval between successive angioedema episodes, disease activity, angioedema-specific and overall QoL impairment were secondary objectives. Methods X-ACT was a phase III, rand…

AdultMalemedicine.medical_specialtyAdolescentUrticariamedicine.medical_treatmentImmunologyDrug ResistanceOmalizumabOmalizumabPlacebolaw.inventionYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifeimmune system diseaseslawInternal medicineAnti-Allergic AgentsmedicineHumansImmunology and AllergyAngioedemaYoung adultskin and connective tissue diseasesAdverse effectAgedAngioedemabusiness.industryMiddle AgedTreatment Outcome030228 respiratory systemAnesthesiaChronic DiseaseRetreatmentHistamine H1 AntagonistsQuality of LifeFemaleAntihistaminemedicine.symptombusinessmedicine.drugAllergy
researchProduct

Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy

2018

Abstract BACKGROUND: Psoriasis is a chronic, recurrent, and immune-mediated inflammatory disease that affects 2-3% of the world population. A substantial proportion of patients with psoriasis, approximately 40 %, develop a form of inflammatory arthritis known as psoriatic arthritis (PsA), the arthritis follows the development of psoriasis, and it will develop simultaneously or possibly before the appearance of skin lesions. The presence of PsA indicates a need for more active intervention rather than purely topical therapies or UV-based therapies. The aim of this multicenter, retrospective, epidemiological study was to estimate the incidence of PsA in psoriatic patients receiving UV treatme…

AdultMalemedicine.medical_specialtyAlcohol DrinkingInflammatory arthritisAnti-Inflammatory AgentsArthritisDermatologyComorbidityAsymptomatic030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritis0302 clinical medicineRisk FactorsPsoriasismedicineHumansPsoriasisObesityMetabolic SyndromePast medical historybusiness.industryIncidence (epidemiology)Arthritis PsoriaticSmokingMiddle Agedmedicine.diseaseDermatologyAdipose TissueCardiovascular DiseasesPsoriatic arthritisPopulation studyCytokinesFemaleUltraviolet Therapymedicine.symptomWaist CircumferencebusinessImmunosuppressive Agents
researchProduct

Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of…

2005

Summary Background  There is evidence that a higher skin susceptibility may induce nonspecific erythematous or weak positive reactions to contact allergens in patch testing. Objectives  To evaluate whether simultaneous application of sodium lauryl sulphate (SLS) along with diagnostic patch tests with contact allergens can provide information regarding skin irritability which may help to discriminate allergic from nonspecific irritant reactions to contact allergens. Methods  Between July 2001 and June 2003, this prospective study collected patch test data of 5971 patients from 19 centres in Germany and Austria in the Information Network of Departments of Dermatology (IVDK). In addition to co…

AdultMalemedicine.medical_specialtyAllergyPathologyErythemaCocamidopropyl betaineDermatologymedicine.disease_causeDermatitis ContactDermatitis AtopicDiagnosis Differential030207 dermatology & venereal diseases03 medical and health sciencesBenzalkonium chloridechemistry.chemical_compound0302 clinical medicineAllergenPredictive Value of TestsMedicineHumansProspective StudiesDiagnostic Errorsintegumentary systembusiness.industryPatch testSodium Dodecyl SulfateAllergensPatch Testsmedicine.diseaseDermatology3. Good healthchemistryDermatitis OccupationalErythema030220 oncology & carcinogenesisDermatitis Allergic ContactFemalemedicine.symptomIrritationbusinessContact dermatitismedicine.drugThe British journal of dermatology
researchProduct

Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine : a multicentre investigation of the German Contact Derma…

2011

Background. p-Phenylenediamine (PPD) 1% in petrolatum has been shown in a prospective study to elicit late reactions in 1.5% of routine patch tests, which may be indicative of patch test sensitization. Objectives. To assess the frequency of late reactions to reduced PPD patch test concentrations. Methods. In 1838 patients, PPD was tested at three concentrations (0.5% pet., group I; 0.4% pet., group II; and 0.35% pet., group III). Patch tests were read on D1 (D2) to D3 (D4); additional late readings were performed on D7, D14, and D21. Patients who were not able to return for all scheduled late readings were telephoned on D7, D14, and D21, and questioned about a reaction at the patch test sit…

AdultMalemedicine.medical_specialtyAllergyTime FactorsMedizinDermatologyPhenylenediaminesGastroenterology030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineImmunopathologyInternal medicineImmunology and AllergyMedicineHumans030212 general & internal medicineProspective cohort studySensitizationbusiness.industryPatch testp-PhenylenediamineMiddle AgedPatch Testsmedicine.disease3. Good healthSurgerymedicine.anatomical_structurechemistryPatch test sensitizationDermatitis Allergic ContactFemalebusinessContact dermatitis
researchProduct

Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis

2008

Psoriasis and psoriatic arthritis are common diseases associated with considerable morbidity and disability. Their pathophysiology comprises similar processes leading to inflammation of skin, entheses, and joints. Although traditional systemic agents can be effective, their use may be limited by lack of efficacy and concerns regarding adverse effects. The objective of this study was to assess the efficacy and safety of adalimumab, a fully human antitumor necrosis factor (anti-TNF) monoclonal antibody, over 16 weeks. The present authors report their personal experience in 15 patients with severe plaque psoriasis and psoriatic arthritis, refractory to other treatments, in which a decisive reg…

AdultMalemedicine.medical_specialtyAnti-Inflammatory AgentsArthritisDermatologyAntibodies Monoclonal HumanizedSeverity of Illness IndexPsoriasis Psoriatic ArthritisPsoriatic arthritisPsoriasisSeverity of illnessSettore MED/35 - Malattie Cutanee E VenereemedicineAdalimumabHumansPsoriasisAdverse effectTumor Necrosis Factor-alphabusiness.industryArthritis PsoriaticAdalimumabAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseDermatologyRadiographyClinical trialTreatment OutcomeMonoclonalFemalebusinessmedicine.drugDermatologic Therapy
researchProduct